UWorld Internal Medicine Practice Test

The primary prevention strategy for a patient with a known history of deep venous thrombosis (DVT) is anticoagulation therapy. This approach is crucial because individuals who have previously experienced DVT are at a significantly increased risk of recurrence. Anticoagulation therapy helps prevent the formation of new blood clots by inhibiting various factors in the coagulation cascade. By using anticoagulants, healthcare providers aim to lower the risk of future thromboembolic events, ensuring better outcomes for patients with a predisposition to clotting disorders. Long-term anticoagulation is particularly recommended for patients with unprovoked DVT or those with additional risk factors for clot formation. While compression stockings, regular exercise, and monitoring of symptoms are all important aspects of managing overall vascular health and may play supportive roles in the context of DVT, they do not serve as the primary prevention strategy. Compression stockings can help manage symptoms and reduce swelling but do not prevent clot formation. Regular exercise contributes positively to circulation but is not a direct preventive measure against DVT recurrence. Monitoring of symptoms is essential for managing existing conditions but does not actively prevent future occurrences of thrombosis. Thus, anticoagulation therapy remains the cornerstone of primary prevention in this context.